how many people use glp-1 drugs trends 2025: real-world data, patient outcomes & future therapies Market Overview: GLP-1 Agonists and

Use features like bookmarks, note taking and highlighting while reading The Ultimate GLP-1 Cookbook: Eating Well For Weight Loss Success.

Key Report Takeaways By mechanism of action, GLP-1 receptor agonists led with 38.55% of the anti-obesity drugs market share in 2025

FDA Oral Wegovy Approval: What the December 22, 2025 Decision Means The FDA's approval of the Wegovy pill represents the first oral GLP-1 medication cleared specifically for weight loss

10.1111/dom.13924 [DOI] [PubMed] [Google Scholar] Abraham, K

Similarly, GLP-1 receptor agonist use was associated with an increased risk of suicidality compared with SGLT-2 inhibitors in crude analyses (crude incidence rates 4.3 v 2.7 per 1000 person years